Anti-TNFSF5/CD40L/CD154 Antibody (Letolizumab)
Catalog No.
F1080
Anti-TNFSF5/CD40L/CD154 Antibody (Letolizumab)
Featured Products
Letolizumab (BMS-986004) is a monoclonal antibody targeting CD40L that was generated to express a mutant IgG1 lacking effector functions, including Fc binding and complement fixation. Letolizumab reduced rejection, thromboembolism, and prolonged survival.
39 kDa
Dry ice
1450981-87-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BMS-986004
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29965
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF5 / CD40L / CD154
Please avoid freeze-thaw cycles.